ArticleTranslational andrology and urology2024
Predictive factors of stress urinary incontinence after Holmium Laser Enucleation of the Prostate: a magnetic resonance imaging-based retrospective study.
Article in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Single-port transvesical enucleation of the prostate (STEP) for benign prostatic hyperplasia: a comparative analysis of patients with large (80-150cc) and very large (>150cc) prostate volumes.Prostate cancer and prostatic diseases · 2026Article
- Anatomical interpretation of membranous urethral length and posterior periurethral thickness after HoLEP: a commentary on Nagasaki et al.World journal of urology · 2026Article
- Preoperative membranous urethral length predicts quality-of-life recovery and urinary incontinence after holmium enucleation of the prostate.World journal of urology · 2026Article
- Preoperative MRI-derived anatomical predictors of urinary incontinence after holmium laser enucleation of the prostate: a systematic review and meta-analysis.International urology and nephrology · 2026Review
- Membranous urethral length as a predictor for urinary incontinence after holmium enucleation of the prostate for benign prostatic hyperplasia.World journal of urology · 2026Observational
- P.I. nomogram: an exploratory imaging-derived model for predicting early urinary incontinence following ThuLEP.World journal of urology · 2026Article
- The Implementation of Trifecta Score to Assess the Quality of Holmium Laser Enucleation of the Prostate in Elderly Patients: An Analysis of Perioperative and Functional Outcomes and the Impact of Age.Journal of clinical medicine · 2025Article
- Influence of preoperative indwelling urinary catheter on outcomes of high-power holmium laser enucleation for very large prostate (≥ 200 mL).World journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stress urinary incontinence (SUI) remains a prevalent complication after Holmium Laser Enucleation of the Prostate (HoLEP). This retrospective analysis aims to delineate perioperative and anatomical determinants of SUI as observed on preoperative multiparametric magnetic resonance imaging (mpMRI) in patients subjected to HoLEP. Methods: We reviewed 216 benign prostatic hyperplasia (BPH) cases managed via HoLEP by a singular urologist at Sun Yat-sen Memorial Hospital from January 2021 to September 2022. Comprehensive medical documentation, including age, body mass index (BMI), prostate volume (PV), total prostate-specific antigen (tPSA), and perioperative variables: operative time (OT), enucleated prostate volume (EPV), were assessed. Detailed analyses of preoperative prostate mpMRI scans were conducted to measure factors such as thickness of the posterior wall of the membranous urethral sphincter (TPWMUS), membranous urethral length (MUL), membranous urethral volume (MUV), and prostatic apex morphology. Results: The cohort encompassed 216 participants, among whom 45 (20.83%) experienced SUI subsequent to one month of HoLEP therapy. At three months, 23 individuals exhibited recovery, reducing the prevalence of SUI to 10.19%. By the six-month milestone, the incidence further declined to 1.38%, with 19 patients reporting normalization of continence. Binary logistic regression analysis identified OT, TPWMUS, and prostatic apex and membranous urethral overlap (PAOMU) emerged as independent risk factors for SUI, while MUV was identified as a protective factor. Conclusions: The risk of SUI post-HoLEP is significantly associated with OT, TPWMUS, and PAOMU, while MUV imparting a protective effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.